Numinus Wellness (NUMI.T) has moved into the implementation part of their MDMA-assisted psychotherapy trial for post-traumatic stress disorder (PTSD) clinical trial by enrolling and dosing its first volunteer. Numinus…
maps mdma phase 3 study
$144.185M Market Capitalization Numinus Wellness Inc. (NUMI.T) announced today that it has completed key steps in preparation for enrollment at the Company’s clinics participating in a “multi-site open-label extension…
Phase 3 Today MAPS released the results of its highly anticipated phase 3 MDMA assisted therapy for severe PTSD study. The results are what many, including myself, anticipated –…